Some examples and use cases from the internet:

Some examples and use cases from the internet:

• Cases of bronchial anastomotic dehiscence, most fatal, have been reported in de novo lung transplant patients when sirolimus has been used as part of an immunosuppressive regimen.
• The safety and efficacy of Neulasta administration in de novo AML patients aged < 55 years with cytogenetics t(15; 17) have not been established.
• 17 years) (see section 4.2).
• The Committee for Medicinal Products for Human Use (CHMP) decided that Simulect's benefits are greater than its risks for the prophylaxis of acute organ rejection in de novo allogeneic renal transplantation in adult and paediatric patients.
• controlled studies.
• blind placebo
• Clinical studies The efficacy of basiliximab in prophylaxis of organ rejection in de novo renal transplantation has been demonstrated in double
• Simulect is indicated for the prophylaxis of acute organ rejection in de novo allogeneic renal transplantation in adult and paediatric patients (1

• One (1) additional low
• Paediatrics The pharmacokinetics of basiliximab were assessed in 39 paediatric de novo renal transplantation patients.
• This adverse reaction was most common in the first 6 months of treatment, and seldom occurred de novo after that time.
• This adverse reaction was most common in the first 6 months of treatment, and seldom occurred de novo after that time.
• Renal function was not better in the treatment arms with de novo Rapamune without a calcineurin inhibitor.
• Limited clinical data suggest a comparable effect on time to recovery of severe neutropenia for pegfilgrastim to filgrastim in patients with de novo acute myeloid leukaemia (see section 5.1).
• titre de novo inhibitor was observed.
• The safety and efficacy of Neulasta administration in de novo AML patients aged < 55 years with cytogenetics t(15; 17) have not been established.